Issued Patents All Time
Showing 1–17 of 17 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 11814679 | Interleukin-10 production of antigen-specific CD8+ T cells and methods of use of same | John Brian Mumm, Ivan Ho Chan, Scott McCauley, Scott Ogg | 2023-11-14 |
| 11648296 | IL-2 orthologs and methods of use | Paul-Joseph Penaflor-Aspuria, Scott McCauley, Steve Kauder | 2023-05-16 |
| 11491205 | Biased IL2 muteins methods and compositions | Jan Emmerich, Steve Kauder, Scott McCauley | 2022-11-08 |
| 11413332 | Methods of using interleukin-10 for treating diseases and disorders | John Brian Mumm, Ivan Ho Chan | 2022-08-16 |
| 10653751 | Methods of treating cancer metastasis by using interleukin-10 | — | 2020-05-19 |
| 10568968 | Methods for treatment of cancer with therapeutic combinations comprising PEG-IL-10 | Catherine Sheppard, John Brian Mumm, Lingling Wu | 2020-02-25 |
| 10357545 | Methods of using interleukin-10 for treating solid tumors | — | 2019-07-23 |
| 10143726 | Methods of using interleukin-10 for treating diseases and disorders | — | 2018-12-04 |
| 9970944 | Methods of modulating cytokine activity; related reagents | Jochen Schmitz, Robert A. Kastelein, J. Fernando Bazan | 2018-05-15 |
| 9943568 | Methods of using pegylated interleukin-10 for treating cancer | — | 2018-04-17 |
| 9833514 | Use of pegylated IL-10 to treat cancer | Catherine Sheppard, John Brian Mumm, Lingling Wu | 2017-12-05 |
| 9364517 | Method of treatment of lymphoma with pegylated IL-10 | Catherine Sheppard, John Brian Mumm, Lingling Wu | 2016-06-14 |
| 8865652 | Method of treating solid cancers with pegylated IL-10 | Catherine Sheppard, John Brian Mumm, Lingling Wu | 2014-10-21 |
| 8822405 | Uses of mammalian cytokines and agonists; related reagents | — | 2014-09-02 |
| 8034341 | Methods of inhibiting tumor growth using blocking antibodies to IL-23R | Terrill K. McClanahan | 2011-10-11 |
| 7282204 | Uses of IL-23 agonists and antagonists; related reagents | Terrill K. McClanahan | 2007-10-16 |
| 6383733 | Methods of screening for pharmacologically active compounds for the treatment of tumour diseases | Hartmut Beug, Ernst Reichmann, Karl-Heinz Heider | 2002-05-07 |